Bioactive mesoporous silica nanostructures with anti-microbial and anti-biofilm properties (original) (raw)
Related papers
Pharmaceutics, 2021
This review focuses on the design of mesoporous silica nanoparticles for infection treatment. Written within a general context of contributions in the field, this manuscript highlights the major scientific achievements accomplished by professor Vallet-Regí’s research group in the field of silica-based mesoporous materials for drug delivery. The aim is to bring out her pivotal role on the envisage of a new era of nanoantibiotics by using a deep knowledge on mesoporous materials as drug delivery systems and by applying cutting-edge technologies to design and engineer advanced nanoweapons to fight infection. This review has been divided in two main sections: the first part overviews the influence of the textural and chemical properties of silica-based mesoporous materials on the loading and release of antibiotic molecules, depending on the host–guest interactions. Furthermore, this section also remarks on the potential of molecular modelling in the design and comprehension of the perfo...
International Journal of Nanomedicine, 2021
It is a fact that the use of antibiotics is inducing a growing resistance on bacteria. This situation is not only the consequence of a drugs’ misuse, but a direct consequence of a widespread and continuous use. Current studies suggest that this effect could be reversed by using abandoned antibiotics to which bacteria have lost their resistance© , but this is only a temporary solution that in near future would lead to new resistance problems. Fortunately, current nanotechnology offers a new life for old and new antibiotics, which could have significantly different pharmacokinetics when properly delivered; enabling new routes able to bypass acquired resistances.© In this contribution, we will focus on the use of porous silica nanoparticles as functional carriers for the delivery of antibiotics and biocides in combination with additional features like membrane sensitizing and heavy metal-driven metabolic- disrupting therapies as two of the most interesting combination therapies.
Mesoporous Silica‐Based Materials with Bactericidal Properties
Small, 2019
Bacterial infections are the main cause of chronic infections and even mortality. In fact, due to extensive use of antibiotics and, then, emergence of antibiotic resistance, treatment of such infections by conventional antibiotics has become a major concern worldwide. One of the promising strategies to treat infection diseases is the use of nanomaterials. Among them, mesoporous silica materials (MSMs) have attracted burgeoning attention due to high surface area, tunable pore/particle size, and easy surface functionalization. This review discusses how one can exploit capacities of the MSMs to design and fabricate multifunctional/controllable drug delivery systems (DDSs) to combat bacterial infections. At first, it describes emergency 2 of bacterial and biofilm resistance towards conventional antimicrobials and then discusses how nanoparticles exert their toxic effects upon pathogenic cells. Next, it introduces the main aspects of MSMs (e.g. physico-chemical properties, multifunctionality and biosafety) which one should consider in the design of MSM-based DDSs against bacterial infections. Finally, a comprehensive analysis of all the papers published dealing with the use of MSMs for delivery of antibacterial chemicals (antimicrobial agents functionalized/adsorbed on mesoporous silica (MS), MS-loaded with antimicrobial agents, gated MS-loaded with antimicrobial agents, MS with metal-based nanoparticles and MS-loaded with metal ions) is provided.
Mesoporous silica as a natural antimicrobial carrier
Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2011
Mesoporous silica structures were synthesized as MCM-41 and SBA-15 from two different mole ratios of their constituents to test their capacity and feasibility for the controlled release of the natural antimicrobial allyl isothiocyanate (AITC). Pore filling by vapor phase AITC approached 100%. Infrared spectroscopy of the adsorbed phase confirmed it to be liquid-like. Controlled release as desorption was dictated by the pore size distribution of each material with up to 90% of the available AITC desorbed over 96 h. Release from the SBA-15 systems occurred as a "burst release" with 65% desorbed in the first 12 h compared with only 20% from the MCM-41 systems. The antimicrobial activity of the released (vapor-phase) ATIC was compared with that from liquid AITC in tests with the microorganisms Escherichia coli, Bacillus cereus, and Pichia anomola. The lethal activity of the released AITC against these microorganisms was unaffected by adsorption and desorption processes, demonstrating the MCM-41 and SBA-15 mesoporous silica structures represent a novel controlled release vector against selected food-borne pathogenic microorganisms.
Mesoporous Silica Materials as Drug Delivery: "The Nightmare" of Bacterial Infection
Pharmaceutics, 2018
Mesoporous silica materials (MSM) have a great surface area and a high pore volume, meaning that they consequently have a large loading capacity, and have been demonstrated to be unique candidates for the treatment of different pathologies, including bacterial infection. In this text, we review the multiple ways of action in which MSM can be used to fight bacterial infection, including early detection, drug release, targeting bacteria or biofilm, antifouling surfaces, and adjuvant capacity. This review focus mainly on those that act as a drug delivery system, and therefore that have an essential characteristic, which is their great loading capacity. Since MSM have advantages in all stages of combatting bacterial infection; its prevention, detection and finally in its treatment, we can venture to talk about them as the "nightmare of bacteria".
International Journal of Pharmacy and Pharmaceutical Sciences, 2016
Objective: To synthesize mesoporous silica nanoparticles using the sol-gel method and to determine the antibacterial activity of mesoporous silica nanoparticles and tetracycline loaded mesoporous silica nanoparticles. Methods: In the synthetic procedure, the surfactant Cetyl Trimethyl Ammonium Bromide (CTAB) is initially dissolved in basic aqueous solution, and the mixture is vigorously stirred. Tetra Ethyl Ortho Silicate (TEOS) is added, and the solution is kept stirring for 6 h. After the reaction is complete, the as-synthesized product is filtered and washed with deionized water. The antibacterial was tested using disc diffusion method and minimum bactericidal concentration (MBC). Results: The synthesized mesoporous silica nanoparticles were characterized by using Scanning Electron Microscope (SEM) micrographs showed spherical particles with an average size of 350 nm. The powder X-Ray Diffraction (XRD) analysis of the material further confirmed the crystallinity of the mesopores as evidenced by the diffraction pattern of an intense peak at θ=24 º. Fourier Transf orm Infra Red Spectroscopy (FTIR) indicated the involvement of carboxyl, amine and hydroxyl groups in the synthetic process. The result shows the inhibitory growth zone of 20 mm and 18 mm for tetracycline loaded mesoporous silica nanoparticles against Escherichia coli and Staphylococcus aureus respectively. Conclusion: To summarize, it has been experimentally demonstrated that mesoporous silica nanoparticle and tetracycline loaded mesoporous silica nanoparticles show very good antimicrobial behavior against the gram-positive (Staphylococcus aureus) and gram negative (Escherichia coli) bacteria.
Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment
International Journal of Molecular Sciences
The rise of antibiotic resistance and the growing number of biofilm-related infections make bacterial infections a serious threat for global human health. Nanomedicine has entered into this scenario by bringing new alternatives to design and develop effective antimicrobial nanoweapons to fight against bacterial infection. Among them, mesoporous silica nanoparticles (MSNs) exhibit unique characteristics that make them ideal nanocarriers to load, protect and transport antimicrobial cargoes to the target bacteria and/or biofilm, and release them in response to certain stimuli. The combination of infection-targeting and stimuli-responsive drug delivery capabilities aims to increase the specificity and efficacy of antimicrobial treatment and prevent undesirable side effects, becoming a ground-breaking alternative to conventional antibiotic treatments. This review focuses on the scientific advances developed to date in MSNs for infection-targeted stimuli-responsive antimicrobials delivery...
Incorporation of antimicrobial compounds in mesoporous silica film monolith
Biomaterials, 2009
Incorporation of the antimicrobial peptide LL-37 (LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES), as well as low molecular weight antimicrobial chlorhexidine, into mesoporous silica was obtained using an EISA one-pot synthesis method. FTIR confirmed efficient encapsulation of both LL-37 and chlorhexidine into mesoporous silica, while XRD and TEM showed that antimicrobial agent incorporation can be achieved without greatly affecting the structure of the mesoporous silica. The modified mesoporous silica released LL-37 and chlorhexidine slowly, reaching maximum release after about 200 h. The release rate could also be controlled through incorporation of SH groups in the pore walls, adding to pore hydrophobicity and reducing the release rate by about 50% compared to the unmodified mesoporous silica. Mesoporous silica containing either LL-37 or chlorhexidine displayed potent bactericidal properties against both Grampositive Staphylococcus aureus and Gram-negative Escherichia coli. While chlorhexidine-loaded mesoporous silica displayed an accompanying high toxicity, as judged from hemolysis, LDH release, and MTT assay, the corresponding material containing LL-37 showed very low toxicity by all these assays, comparable to that observed for mesoporous silica in the absence of antibacterial drug, as well as to the negative controls in the respective assays. Mesoporous silica containing LL-37 therefore holds potential as an implantable material or a surface coating for such materials, as it combines potent bactericidal action with low toxicity, important features for controlling implant-related infections, e.g., for multiresistant pathogens or for cases where access to the infection site of systemically administered antibiotics is limited due to collagen capsule formation or other factors.
Journal of agricultural and food chemistry, 2018
Antimicrobial agents, such as nisin, are used extensively in the food industry. Here, we investigated various approaches to load nisin onto mesoporous silica nanoparticles (MSNs, 92 ± 10 nm in diameter), to enhance its stability and sustained release. The morphology, size, and surface charge of the as-prepared nanoparticles were analyzed using scanning transmission electron microscopy, dynamic light scattering, and ζ potential measurement. Nisin was either physically adsorbed or covalently attached to the variously functionalized MSNs, with high loading capacities (>600 mg of nisin g of nanoparticles). The results of antibacterial activity analysis of nisin against Staphylococcus aureus showed that, despite the very low antibacterial activity of nisin covalently conjugated onto MSNs, the physical adsorption of nisin onto the unfunctionalized nanoparticles enhances its antimicrobial activities under various conditions, with no significant cytotoxicity effects on mouse fibroblast L...